Social Responsibility

DNC live webcast: opening remarks by the Obamas and Doug Emhoff tonight.

DNC live webcast: opening remarks by the Obamas and Doug Emhoff tonight.

Streaming Notice: Tune in tonight at 6:30 p.m. ET for live coverage of the pivotal night of the Democratic National Convention. If the video player is not visible, please refresh your browser closer to the time of the event. Tonight marks a critical chapter for the Democratic Party as it looks to leadership and future strategies. This shift comes after a tumultuous period that saw President Joe Biden endorse Vice President Kamala Harris as his successor. Evening program 6:30 PM ET: Jason Carter, grandson of former President Jimmy Carter. Jack Schlossberg, grandson of former President John F. Kennedy. 7:00 PM…
Read More
UK homebuyers take advantage of lower mortgage rates following BOE rate cut

UK homebuyers take advantage of lower mortgage rates following BOE rate cut

LONDON — In response to the Bank of England’s recent decision to lower interest rates for the first time in four years, the UK’s major banks have cut mortgage rates, significantly reviving the housing market. Lenders such as Barclays, Halifax, HSBC and NatWest are now offering five-year fixed-rate mortgages at rates below 4%, which is below the BOE’s 5% prime rate. The most competitive of these offers is a five-year fixed rate of 3.83% for homebuyers who can put down a 40% deposit, the latest Rightmove report revealed. This rate is the lowest since the economic fallout from the UK’s…
Read More
Conflicts of interest at the FDA: the intersection between regulation and representation

Conflicts of interest at the FDA: the intersection between regulation and representation

In the tangled corridors of government oversight, Dr. Jeffrey E. Shuren was a prominent figure, heading the Food and Drug Administration’s medical device branch for more than a decade. Leading a team of about 2,500 people, Dr. Shuren oversaw an expansive budget of about $790 million, according to U.S. Senate Health, Education, Labor, and Pensions Committee documents. Dr. Shuren’s tenure has been marked by significant accomplishments, including record approvals of innovative medical devices ranging from joint replacements to infectious disease diagnostics. His leadership was recently praised by FDA Commissioner Dr. Robert Califf, who highlighted the historic number of new device…
Read More
Eli Lilly’s weight-loss drug reduces risk of developing diabetes in long-term trial

Eli Lilly’s weight-loss drug reduces risk of developing diabetes in long-term trial

In a recent long-term research study published Tuesday, Eli Lilly reported that its popular weight-management drug significantly reduced the incidence of type 2 diabetes by 94 percent among overweight or obese adults who had prediabetic symptoms, compared to a control group that received a placebo. The late-stage study explored the effects of tirzepatide, the active compound in both Eli Lilly’s Zepbound weight-loss shot and the diabetes treatment Mounjaro. Over about three years, participants who received the highest weekly dose of tirzepatide experienced an average reduction in body weight of 22.9 percent, while those who took a placebo saw only a…
Read More